Australia's leading breast cancer resource for health professionals
|
Early breast cancerClinical Practice Guidelines for the Management of Early Breast Cancer August 2001
The guidelines are not
rigid procedural paths, nor are they prescriptive. They aim to provide
information on which decisions can be made, rather than dictate
what the decisions should be.
Topic specific guideline updates July 2008 As new evidence becomes available, NBOCC develops topic-specific updates on priority guideline topics as supplements to the Clinical practice guidelines for early breast cancer. Current guideline updates available for early breast cancer are:
|
Clinical Practice Guidelines For The Management Of Early Breast Cancer.
Recommendations for Aromatase inhibitors as adjuvant endocrine therapy
Recommendations for use of sentinel node biopsy in early (operable) breast cancerRecommendations for use of taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancerRecommendations for use of Trastuzumab (Herceptin®) for the treatment of HER2-positive breast cancerThe use of intraoperative radiotherapy - for the treatment of patients with early breast cancer |